Lupus Science & Medicine®
is a global, peer-reviewed, open access lupus journal from LFA, publishing papers on all aspects of lupus and related diseases.
Impact factor: 3.7
Citescore: 5.3
All metrics >>
Publish in LSM
Lupus Science & Medicine considers submissions of a range of article types, including original research, brief communications, study protocols and meeting reports.
Information is also provided on editorial policies and open access.
This is an open access journal that levies an Article Publishing Charge (APC). Discounts and waivers are available; details are provided in the Author Information section.
All manuscripts should be submitted online.
Published articles are discoverable via PubMed, Web of Science, Scopus and Google Scholar.
Latest Articles
Epidemiology and outcomes:
Racial differences in clinical trial perceptions among a large, predominantly Black cohort of people with systemic lupus erythematosus in the Southeastern USA4 January 2025
Immunology and inflammation:
Real-world treatment patterns, healthcare resource utilisation and costs in patients with SLE in the USA23 December 2024
Clinical trials and drug discovery:
Lupus nephritis randomised controlled trials: evidence gaps and under-represented groups20 December 2024
Childhood lupus:
Efficacy of initial combination with belimumab in newly diagnosed childhood-onset lupus nephritis: a single-centre historical control study15 December 2024
Reproductive health and APS:
Non-criteria antiphospholipid antibody profiles and thrombotic outcomes in a cohort of patients with systemic lupus erythematosus12 December 2024
Lupus Academy 2024
Lupus Science & Medicine was delighted to be the official journal of the 13th annual meeting of the Lupus Academy 2024. The meeting took place 6-8 September in Amsterdam, The Netherlands.
The abstracts from the conference were published as a supplement to Lupus Science & Medicine.
LSM Podcasts
Featured Video
Lupus Science & Medicine
The official journal of the Lupus Foundation of America and the premier open-access journal dedicated to lupus research.
Find out moreAltmetrics
Most Read Articles
Review:
Disease-modifying therapies in systemic lupus erythematosus for extrarenal manifestations22 May 2024
Clinical trials and drug discovery:
Mezagitamab in systemic lupus erythematosus: clinical and mechanistic findings of CD38 inhibition in an autoimmune disease7 March 2024
Childhood lupus:
Rituximab as an effective add-on maintenance therapy for disease activities in childhood-onset systemic lupus erythematosus19 January 2024
Related Journals
